Eva M. Briso

IL-6R Ectodomain Shedding in Activated Cutting Edge: Soluble IL-6R Is Produced by

O. Dienz, Eva M. Briso, 2008 .

Cutting Edge: Soluble IL-6R Is Produced by IL-6R Ectodomain Shedding in Activated CD4 T Cells1

M. Rincón, O. Dienz, Eva M. Briso, 2008, The Journal of Immunology.

Inflammation-mediated skin tumorigenesis induced by epidermal c-Fos

R. Eils, E. Wagner, P. Angel, 2013, Genes & development.

The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells

G. Ciliberto, W. Leonard, J. Bond, 2009, The Journal of experimental medicine.

A phase 2 study of ibrutinib in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma

R. Hájek, A. Oriol, A. Anagnostopoulos, 2019, European journal of haematology.

Single-Agent Ibrutinib for Rituximab-Refractory Waldenström Macroglobulinemia: Final Analysis of the Substudy of the Phase III InnovateTM Trial

M. Dimopoulos, C. Buske, S. Treon, 2021, Clinical Cancer Research.

Long-Term Follow-up of Ibrutinib Treatment for Rituximab-Refractory Waldenström's Macroglobulinemia: Final Analysis of the Open-Label Substudy of the Phase 3 iNNOVATETM Trial

M. Dimopoulos, C. Buske, S. Treon, 2020 .